Ralf Stemkens

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Molecularly Imprinted

Pulmonary Tuberculosis

Top Venues

Antimicrobial agents and chemotherapy

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ralf Stemkens, Chaima Mouhdad, Eric J F Franssen, Daniel Touw, Jan Willem C Alffenaar, Lindsey H M Te Brake, Marieke G G Sturkenboom, Rob E Aarnoutse
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Ralf Stemkens, Chaima Mouhdad, Eric J F Franssen, Daniel Touw, Jan Willem C Alffenaar, Lindsey H M Te Brake, Marieke G G Sturkenboom, Rob E Aarnoutse
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse, Elin M Svensson, Khalid Asouit, Erik van den Hombergh, Lindsey Te Brake, Ralf Stemkens, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrobial agents and chemotherapy (2024)
Ralf Stemkens, Chaima Mouhdad, Eric J F Franssen, Daniel Touw, Jan Willem C Alffenaar, Lindsey H M Te Brake, Marieke G G Sturkenboom, Rob E Aarnoutse
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations. The Journal of antimicrobial chemotherapy (2024)
Ralf Stemkens, Chaima Mouhdad, Eric J F Franssen, Daniel Touw, Jan Willem C Alffenaar, Lindsey H M Te Brake, Marieke G G Sturkenboom, Rob E Aarnoutse
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse, Elin M Svensson, Khalid Asouit, Erik van den Hombergh, Lindsey Te Brake, Ralf Stemkens, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse, Elin M Svensson, Khalid Asouit, Erik van den Hombergh, Lindsey Te Brake, Ralf Stemkens, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse, Elin M Svensson, Khalid Asouit, Erik van den Hombergh, Lindsey Te Brake, Ralf Stemkens, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Ralf Stemkens, Veronique de Jager, Rodney Dawson, Andreas H Diacon, Kim Narunsky, Sherman D Padayachee, Martin J Boeree, Stijn W van Beek, Angela Colbers, Marieke J H Coenen, Elin M Svensson, Uwe Fuhr, Patrick P J Phillips, Lindsey H M Te Brake, Rob E Aarnoutse, null null
Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis. Antimicrobial agents and chemotherapy (2023)
Ralf Stemkens, Maarten Cobussen, Erik de Laat, Wouter Hoefsloot, Reinout van Crevel, Rob E Aarnoutse, Jakko van Ingen
Successful addition of topical antibiotic treatment after surgery in treatment-refractory nontuberculous mycobacterial skin and soft tissue infections. Antimicrobial agents and chemotherapy (2023)